Taline V. Khroyan

2.6k citations

49 papers · 2.1k indexed · h-index 30

Cellular and Molecular Neuroscience top 1%
Molecular Biology top 10%
Physiology top 5%
Cognitive Neuroscience top 5%
Social Psychology top 10%

Co-authors: Lawrence Toll Willma E. Polgar Janet L. Neisewander Nurulain T. Zaveri Roger D. Spealman James K. Rowlett Laura E. O’Dell Rita A. Fuchs
Topics: Receptor Mechanisms and Signaling (28 papers)Neuropeptides and Animal Physiology (21 papers)Neurotransmitter Receptor Influence on Behavior (18 papers)
Cited by: Cellular and Molecular Neuroscience Behavioral Neuroscience Physiology
Journals: Journal of Clinical Investigation Brain The FASEB Journal
Partner nations: United States United Kingdom Italy

In The Last Decade

Taline V. Khroyan

49 papers receiving 2.1k citations

Peers

Countries citing papers authored by Taline V. Khroyan

Since Specialization

Citations

This map shows the geographic impact of Taline V. Khroyan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Taline V. Khroyan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Taline V. Khroyan more than expected).

Fields of papers citing papers by Taline V. Khroyan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Taline V. Khroyan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Taline V. Khroyan. The network helps show where Taline V. Khroyan may publish in the future.

Co-authorship network of co-authors of Taline V. Khroyan

This figure shows the co-authorship network connecting the top 25 collaborators of Taline V. Khroyan. A scholar is included among the top collaborators of Taline V. Khroyan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Taline V. Khroyan. Taline V. Khroyan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Synthesis, Biological Evaluation, and SAR Studies of 14β-phenylacetyl Substituted 17-cyclopropylmethyl-7, 8-dihydronoroxymorphinones Derivatives: Ligands With Mixed NOP and Opioid Receptor Profile 2018 ·Frontiers in Psychiatry ·Vinod Kumar,Willma E. Polgar,Gerta Cami‐Kobeci,Mark Thomas,Taline V. Khroyan,Lawrence Toll,Stephen M. Husbands	3
2	Cyclooxygenase inhibition targets neurons to prevent early behavioural decline in Alzheimer’s disease model mice 2016 ·Brain ·Nathaniel S. Woodling,Damien Colas,Qian Wang,Paras S. Minhas,(unknown),Xibin Liang,Siddhita D. Mhatre,Holden D. Brown,(unknown),Irène Zagol-Ikapitte,Marieke van der Hart,Taline V. Khroyan,Bayarsaikhan Chuluun,(unknown),Ginger L. Milne,Arash Rassoulpour,Olivier Boutaud,Amy Manning-Bog,H. Craig Heller,Katrin I. Andreasson	78
3	High affinity α3β4 nicotinic acetylcholine receptor ligands AT-1001 and AT-1012 attenuate cocaine-induced conditioned place preference and behavioral sensitization in mice 2015 ·Biochemical Pharmacology ·Taline V. Khroyan,Dennis Yasuda,Lawrence Toll,Willma E. Polgar,Nurulain T. Zaveri	19
4	Designing bifunctional NOP receptor–mu opioid receptor ligands from NOP-receptor selective scaffolds. Part II 2014 ·Bioorganic & Medicinal Chemistry ·(unknown),Willma E. Polgar,Taline V. Khroyan,Nurulain T. Zaveri	22
5	AT-1001: A High Affinity and Selective α3β4 Nicotinic Acetylcholine Receptor Antagonist Blocks Nicotine Self-Administration in Rats 2012 ·Neuropsychopharmacology ·Lawrence Toll,Nurulain T. Zaveri,Willma E. Polgar,Faming Jiang,Taline V. Khroyan,Wei Zhou,Xinmin Xie,G.B. Stauber,Matthew R. Costello,Frances M. Leslie	66
6	The First Universal Opioid Ligand, (2S)-2-[(5R,6R,7R,14S)-N-cyclopropylmethyl-4,5-epoxy-6,14-ethano-3-hydroxy-6-methoxymorphinan-7-yl]-3,3-dimethylpentan-2-ol (BU08028): Characterization of the In Vitro Profile and In Vivo Behavioral Effects in Mouse Models of Acute Pain and Cocaine-Induced Reward 2010 ·Journal of Pharmacology and Experimental Therapeutics ·Taline V. Khroyan,Willma E. Polgar,Gerta Cami‐Kobeci,Stephen M. Husbands,Nurulain T. Zaveri,Lawrence Toll	56
7	Hypocretin/orexin and nociceptin/orphanin FQ coordinately regulate analgesia in a mouse model of stress-induced analgesia 2008 ·Journal of Clinical Investigation ·Xinmin Xie,Jonathan P. Wisor,Junko Hara,Tara L. Crowder,Robin D. LeWinter,Taline V. Khroyan,Akihiro Yamanaka,Sabrina Diano,Tamas L. Horvath,Takeshi Sakurai,Lawrence Toll,Thomas S. Kilduff	82
8	Genetics of nicotine dependence and pharmacotherapy 2007 ·Biochemical Pharmacology ·Christina N. Lessov‐Schlaggar,Michele L. Pergadia,Taline V. Khroyan,Gary E. Swan	66
9	SR 16435 [1-(1-(Bicyclo[3.3.1]nonan-9-yl)piperidin-4-yl)indolin-2-one], a Novel Mixed Nociceptin/Orphanin FQ/μ-Opioid Receptor Partial Agonist: Analgesic and Rewarding Properties in Mice 2006 ·Journal of Pharmacology and Experimental Therapeutics ·Taline V. Khroyan,Nurulain T. Zaveri,Willma E. Polgar,Juan Orduña,Cris Olsen,Faming Jiang,Lawrence Toll	58
10	Synthesis and in vitro biological evaluation of a carbon glycoside analogue of morphine-6-glucuronide 2005 ·Bioorganic & Medicinal Chemistry Letters ·James M. MacDougall,Xiaodong Zhang,Willma E. Polgar,Taline V. Khroyan,Lawrence Toll,John R. Cashman	9
11	Genetics and Drug Use as a Complex Phenotype 2004 ·Substance Use & Misuse ·Christina N. Lessov,Gary E. Swan,Huijun Z. Ring,Taline V. Khroyan,Caryn Lerman	31
12	Synthesis and biological evaluation of some 6-arylamidomorphines as analogues of morphine-6-glucuronide 2004 ·Bioorganic & Medicinal Chemistry ·James M. MacDougall,Xiaodong Zhang,Willma E. Polgar,Taline V. Khroyan,Lawrence Toll,John R. Cashman	10
13	Dopamine receptor DRD2 genotype and smoking cessation outcome following treatment with bupropion SR 2004 ·The Pharmacogenomics Journal ·Gary E. Swan,Ana M. Valdes,Huijun Z. Ring,Taline V. Khroyan,Lisa M. Jack,Carl C.T. Ton,Susan J. Curry,Tim McAfee	84
14	Environmental and Genetic Determinants of Tobacco Use 2003 ·Cancer Epidemiology and Prevention Biomarkers ·Gary E. Swan,Karen Suchanek Hudmon,Lisa M. Jack,(unknown),Dorit Carmelli,Taline V. Khroyan,Huijun Z. Ring,Hyman Hops,Judy A. Andrews,Elizabeth Tildesley,(unknown),Neal L. Benowitz,Chris Webster,Kirk C. Wilhelmsen,Heidi S. Feiler,Barbara A. Koenig,(unknown),Judy Illes,(unknown)	2
15	Effects of 7-OH-DPAT on cocaine-seeking behavior and on re-establishment of cocaine self-administration 2002 ·Pharmacology Biochemistry and Behavior ·Rita A. Fuchs,Ly T.L. Tran-Nguyen,Suzanne M. Weber,Taline V. Khroyan,Janet L. Neisewander	29
16	Dopaminergic Mechanisms in Relapse to Cocaine‐Seeking Behavior: Implications for Medications Development 2000 ·Annals of the New York Academy of Sciences ·Roger D. Spealman,Taline V. Khroyan,(unknown),James K. Rowlett,Donna M. Platt	4
17	Behavioral interactions produced by co-administration of 7-OH-DPAT with cocaine or apomorphine in the rat 1999 ·Psychopharmacology ·Taline V. Khroyan,Rita A. Fuchs,(unknown),(unknown),Janet L. Neisewander	32
18	Effects of intraaccumbens administration of SCH-23390 on cocaine-induced locomotion and conditioned place preference 1998 ·Synapse ·David L. Baker,Rita A. Fuchs,Sheila E. Specio,Taline V. Khroyan,Janet L. Neisewander	88
19	Dose-dependent characterization of the rewarding and stimulant properties of cocaine following intraperitoneal and intravenous administration in rats 1996 ·Psychopharmacology ·Laura E. O’Dell,Taline V. Khroyan,Janet L. Neisewander	63
20	Dose-dependent effects of the D3-preferring agonist 7-OH-DPAT on motor behaviors and place conditioning 1995 ·Psychopharmacology ·Taline V. Khroyan,David L. Baker,Janet L. Neisewander	60

About Taline V. Khroyan

Taline V. Khroyan is a scholar working on Cellular and Molecular Neuroscience, Behavioral Neuroscience and Molecular Biology, having authored 49 papers that have together received 2.1k indexed citations. Recurring topics across this work include Receptor Mechanisms and Signaling (28 papers), Neuropeptides and Animal Physiology (21 papers) and Neurotransmitter Receptor Influence on Behavior (18 papers). The work is most often cited by research in Cellular and Molecular Neuroscience (1.4k citations), Behavioral Neuroscience (99 citations) and Physiology (611 citations). Taline V. Khroyan has collaborated with scholars based in United States, United Kingdom and Italy. Frequent co-authors include Lawrence Toll, Willma E. Polgar, Janet L. Neisewander, Nurulain T. Zaveri, Roger D. Spealman, James K. Rowlett, Laura E. O’Dell, Rita A. Fuchs, David L. Baker and Faming Jiang. Their work appears in journals such as Journal of Clinical Investigation, Brain and The FASEB Journal.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact